| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.069 | 0.2 |